Ariad Pharmaceuticals Inc fka ARIA

[dubstock]

I'm not suggesting he was performing the experiments himself. If I were to take a guess, though, I would imagine he was probably spending a good amount of time reviewing results ad working with the lab on the significance of their findings and what follow up to be doing. Which is, in my humble opinion, a good thing if you are a CEO trying to make your company a long-term player. You have to be an expert in your field. That is a riskier proposition at this point than cashing out on what you've found and running, though. Which is what I think we all expect within 6 months now.